This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- HO-MeOH-E:
-
Hopea odorata methanol extract
- MACS:
-
Magnetic-activated cell sorting
- TPZ:
-
Tirapazamine
- VN9:
-
Vietnamese breast cancer cell line #9
- VN9CSC:
-
Vietnamese breast cancer stem cell line #9
References
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100(7), 3983–3988.
Baker, L. A., Tiriac, H., Clevers, H., & Tuveson, D. A. (2016). Modeling pancreatic cancer with organoids. Trends in Cancer, 2(4), 176–190.
Breslin, S., & O’Driscoll, L. (2013). Three-dimensional cell culture: The missing link in drug discovery. Drug Discovery Today, 18(5–6), 240–249.
Chen, W., Dong, J., Haiech, J., Kilhoffer, M. C., & Zeniou, M. (2016). Cancer stem cell quiescence and plasticity as major challenges in cancer therapy. Stem Cells International, 2016, 1740936.
Choi, H. S., Kim, S. L., Kim, J. H., Deng, H. Y., Yun, B. S., & Lee, D. S. (2018). Triterpene acid (3-O-p-Coumaroyltormentic acid) isolated from Aronia extracts inhibits breast Cancer stem cell formation through downregulation of c-Myc protein. International Journal of Molecular Sciences, 19(9), pii: E2528.
Chuakul W (2005) Medicinal plants in the Khok Pho district, pattani province (Thailand)
Cruz-Lozano, M., Gonzalez-Gonzalez, A., Marchal, J. A., Munoz-Muela, E., Molina, M. P., Cara, F. E., Brown, A. M., Garcia-Rivas, G., Hernandez-Brenes, C., Lorente, J. A., et al. (2018). Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/beta-catenin and TGFbeta signaling pathways. European Journal of Nutrition, 58(8), 3207–3219.
Cufi, S., Corominas-Faja, B., Vazquez-Martin, A., Oliveras-Ferraros, C., Dorca, J., Bosch-Barrera, J., Martin-Castillo, B., & Menendez, J. A. (2012). Metformin-induced preferential killing of breast cancer initiating CD44+CD24−/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget, 3(4), 395–398.
Dandawate, P. R., Subramaniam, D., Jensen, R. A., & Anant, S. (2016). Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Seminars in Cancer Biology, 40–41, 192–208.
Gangadhara, S., Smith, C., Barrett-Lee, P., & Hiscox, S. (2016). 3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response. BMC Cancer, 16, 345.
Hu, Y., & Fu, L. (2012). Targeting cancer stem cells: A new therapy to cure cancer patients. American Journal of Cancer Research, 2(3), 340–356.
Hubert, C. G., Rivera, M., Spangler, L. C., Wu, Q., Mack, S. C., Prager, B. C., Couce, M., McLendon, R. E., Sloan, A. E., & Rich, J. N. (2016). A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Research, 76(8), 2465–2477.
Imamura, Y., Mukohara, T., Shimono, Y., Funakoshi, Y., Chayahara, N., Toyoda, M., Kiyota, N., Takao, S., Kono, S., Nakatsura, T., et al. (2015). Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncology Reports, 33(4), 1837–1843.
Li, B., Lu, Y., Yu, L., Han, X., Wang, H., Mao, J., Shen, J., Wang, B., & Tang, J. (2017). Li C et al: miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-kappaB/COX-2 activation. Chemico-Biological Interactions, 277, 33–42.
Li, W., Hu, X., Yang, S., Wang, S., Zhang, C., Wang, H., Cheng, Y. Y., Wang, Y., Liu, T., & Song, K. (2018). A novel tissue-engineered 3D tumor model for anti-cancer drug discovery. Biofabrication, 11(1), 015004.
Lin, W. H., Yeh, S. H., Yeh, K. H., Chen, K. W., Cheng, Y. W., Su, T. H., Jao, P., Ni, L. C., Chen, P. J., & Chen, D. S. (2016). Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 113(42), 11937–11942.
Luo, M., Clouthier, S. G., Deol, Y., Liu, S., Nagrath, S., Azizi, E., & Wicha, M. S. (2015). Breast cancer stem cells: Current advances and clinical implications. Methods in Molecular Biology (Clifton, NJ), 1293, 1–49.
Nguyen, T., Tran, T. H., Nguyen, M. D., Sierens, T., & Triest, L. (2014). Genetic population of threatened Hopea odorata Roxb. In the protected areas of Vietnam. Journal of Vietnamese Environment, 6(1), 69–76.
Nguyen, S. T., Huynh, K. L., Nguyen, H. L.-T., Nguyen Thi Thanh, M., Nguyen Trung, N., Nguyen Xuan, H., Ngoc, K. P., Truong Dinh, K., & Pham, P. V. (2017). Hopea odorata extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis. Oncotargets and Therapy, 10, 5765–5774.
Pham, P. V., Phan, N. L., Nguyen, N. T., Truong, N. H., Duong, T. T., Le, D. V., Truong, K. D., & Phan, N. K. (2011). Differentiation of breast cancer stem cells by knockdown of CD44: Promising differentiation therapy. Journal of Translational Medicine, 9(1), 209.
Polonio-Alcala, E., Rabionet, M., Ruiz-Martinez, S., Ciurana, J., & Puig, T. (2018). Three-dimensional manufactured supports for breast cancer stem cell population characterization. Current Drug Targets, 20(8), 839–851.
Prasad, P. R. C., Reddy, C. S., Raza, S., & Dutt, C. J. F. (2008). Folklore medicinal plants of North Andaman Islands, India. Fitoterapia, 79(6), 458–464.
Quayle, L. A., Ottewell, P. D., & Holen, I. (2018). Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention. Clinical & Experimental Metastasis, 35(8), 831–846.
Rabacow, A. P. M., Meza, A., De Oliveira, E. J. T., De David, N., Vitor, N., Antoniolli-Silva, A., De Fatima Cepa Matos, M., Perdomo, R. T., Da Silva Gomes, R., De Lima, D. P., et al. (2018). Evaluation of the antitumor potential of the resorcinolic lipid 3-Heptyl-3,4,6-trimethoxy-3H-isobenzofuran-1-one in breast cancer cells. Anticancer Research, 38(8), 4565–4576.
Rabinovich, I., Sebastiao, A. P. M., Lima, R. S., Urban, C. A., Junior, E. S., Anselmi, K. F., Elifio-Esposito, S., & De Noronha, L. (2018). Moreno-Amaral AN: Cancer stem cell markers ALDH1 and CD44+/CD24− phenotype and their prognosis impact in invasive ductal carcinoma. European Journal of Histochemistry, 62(3), 2943.
Richichi, C., Brescia, P., Alberizzi, V., Fornasari, L., & Pelicci, G. (2013). Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma. Neoplasia (New York, NY), 15(7), 840–847.
Shao, J., Fan, W., Ma, B., & Wu, Y. (2016). Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics. Molecular Medicine Reports, 14(6), 4991–4998.
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014). 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Advanced Drug Delivery Reviews, 69–70, 29–41.
Van Phuc, P., Nhan, P. L., Nhung, T. H., Tam, N. T., Hoang, N. M., Tue, V. G., Thuy, D. T., & Ngoc, P. K. (2011). Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells. Oncotargets and Therapy, 4, 71–78.
Wicha, M. S. (2008). Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Research, 10(2), 105.
Yang, Y., Yu, T., Gyu Lee, Y., Seok Yang, W., Oh, J., Jeong, D., Lee, S., Woong Kim, T., Chul Park, Y., Sung, G.-H., et al. (2013). Methanol extract of Hopea odorata suppresses inflammatory responses via the direct inhibition of multiple kinases. Journal of Ethnopharmacology, 145(2), 598–607.
Yenigun, V. B., Ozpolat, B., & Kose, G. T. (2013). Response of CD44+/CD24−/low breast cancer stem/progenitor cells to tamoxifen and doxorubicin-induced autophagy. International Journal of Molecular Medicine, 31(6), 1477–1483.
Yildiz-Ozturk, E., Gulce-Iz, S., Anil, M., & Yesil-Celiktas, O. (2017). Cytotoxic responses of carnosic acid and doxorubicin on breast cancer cells in butterfly-shaped microchips in comparison to 2D and 3D culture. Cytotechnology, 69(2), 337–347.
Yin, H., & Glass, J. (2011). The phenotypic radiation resistance of CD44+/CD24(−or low) breast cancer cells is mediated through the enhanced activation of ATM signaling. PLoS One, 6(9), e24080.
Zurinah, W. N. (2012). An evaluation of the anticancer activity in Hopea odorata extracts. Journal of Medicinal Plants Research, 6(8), 1382–1388.
Acknowledgments
This work was supported by the Vietnam National University, Ho Chi Minh City, Vietnam, under grant A2015-18-01.
Conflict of Interest
The authors declare that there is no conflict of interests regarding the publication of this article.
Author Contributions
NL-CP designed the project, carried out the experiments, analyzed the data, and wrote the paper draft. KDP and PLM contributed to feasibility experiments. MTTN prepared and provided the extract. PVP, KDT, and NPK suggested the idea, analyzed the results, corrected the scientific matters and English wording, and review all paper. All authors approved the final version of manuscript for submission.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Phan, N.LC. et al. (2020). Hopea odorata Extract Can Efficiently Kill Breast Cancer Cells and Cancer Stem-Like Cells in Three-Dimensional Culture More Than in Monolayer Cell Culture. In: Pham, P.V. (eds) Cancer Biology and Advances in Treatment. Advances in Experimental Medicine and Biology(), vol 1292. Springer, Cham. https://doi.org/10.1007/5584_2020_524
Download citation
DOI: https://doi.org/10.1007/5584_2020_524
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57253-2
Online ISBN: 978-3-030-57254-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)